Skip to content

SGMT - Sagimet Biosciences Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchS

Sagimet Biosciences Inc. Series A Common Stock

SGMT · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

S

SGMTSagimet Biosciences Inc. Series A Common Stock

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $11.15
52-wk low: $4.50
Prev close: $8.07
Mkt cap: $657.6M
Beta: 3.40
P/S: 52.5x

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$113.6M

BA
Balyasny
Dmitry Balyasny · Q2 2026 13F
$28.0M
position
MI
Millennium

Earnings

Reported Aug 11, 2026

Earnings came in 7.1% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $658M

Valuation

P/S52.50
P/B2.53

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: SGMT
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $657.64M
Beta: 3.40

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

2.5x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-24.4%

Israel Englander · Q2 2026 13F

$7.2M

position

MW

Marshall Wace

Q1 2026 13F

$5.0M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for SGMT

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.26+7.1%

-$0.28 expected

Next report

What the street expects next

EPS expected

-$0.25

-$0.28 to -$0.16

Revenue expected

$0.00

9 analysts

Last 30 days

7up0down

Analysts raising estimates

Estimate drift

+0.02

Change in 30 days

-24.4%

ROA-16.4%

Growth

Beta3.40